gemfibrozil · Powder

What changed in the last 90 days

Every detected change for gemfibrozil, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Peroxisome Proliferator Receptor alpha Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• alogliptin and pioglitazone· 1 maker
• pioglitazole and metformin hydrochloride· 1 maker
• pioglitazone hcl and metformin hcl· 1 maker
• alogliptin benzoate and pioglitazone hydrochloride· 2 makers
• pioglitazone and glimepiride· 3 makers
• pioglitazone and metformin hydrochloride· 3 makers
• pioglitazone hydrochloride and metformin hydrochloride· 3 makers
• fenofibric acid· 11 makers
• pioglitazone· 19 makers
• pioglitazone hydrochloride· 19 makers
• fenofibrate· 66 makers

Common questions

Is Gemfibrozil in shortage right now?

No. FDA does not currently list Gemfibrozil in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Gemfibrozil?

31 companies have marketed Gemfibrozil in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

What does Gemfibrozil cost?

The typical pharmacy pays about $0.1045 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.